BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,514	18,162	19,234	16,220	15,918	15,187
Market Cap Growth	-19.63%	-5.57%	18.58%	1.90%	4.81%	0.17%
Enterprise Value	12,186	18,132	19,051	16,229	15,917	15,375
Last Close Price	65.66	96.42	103.49	88.35	87.69	84.55
PE Ratio	39.07	108.34	135.87	-	18.64	-
Forward PE	18.29	38.98	39.00	85.79	75.56	59.78
PS Ratio	4.52	7.51	9.18	8.79	8.56	8.91
PB Ratio	2.31	3.67	4.18	3.80	3.88	4.86
P/TBV Ratio	2.70	4.10	4.73	4.41	4.56	6.15
P/FCF Ratio	39.12	290.28	350.06	77.63	-	-
P/OCF Ratio	30.18	114.04	109.34	53.26	186.47	314.68
PEG Ratio	0.74	1.07	0.86	2.66	1.75	0.96
EV/Sales Ratio	4.43	7.49	9.09	8.79	8.56	9.02
EV/EBITDA Ratio	28.60	65.58	111.45	481.22	1186.81	34707.47
EV/EBIT Ratio	37.33	105.36	276.25	-	-	-
EV/FCF Ratio	38.09	289.80	346.74	77.67	-	-
Debt / Equity Ratio	0.11	0.23	0.24	0.26	0.28	0.29
Debt / EBITDA Ratio	1.37	3.90	6.07	23.56	43.10	67.53
Debt / FCF Ratio	1.88	18.12	20.38	5.38	-	-
Asset Turnover	0.40	0.37	0.34	0.31	0.35	0.37
Inventory Turnover	1.19	1.26	1.36	1.49	1.67	1.77
Quick Ratio	2.39	1.45	2.98	2.54	3.07	1.21
Current Ratio	4.27	2.51	4.67	4.16	4.76	2.08
Return on Equity (ROE)	6.25%	3.51%	3.19%	-1.53%	23.63%	-0.78%
Return on Assets (ROA)	3.00%	1.63%	0.70%	-0.78%	-1.09%	-1.44%
Return on Capital (ROIC)	3.40%	1.82%	0.78%	-0.87%	-1.24%	-1.67%
Earnings Yield	2.58%	0.92%	0.74%	-0.40%	5.37%	-0.16%
FCF Yield	2.56%	0.34%	0.29%	1.29%	-0.18%	-0.64%
Buyback Yield / Dilution	-0.93%	-1.39%	-3.34%	4.60%	-7.06%	-1.00%
Total Shareholder Return	-0.93%	-1.39%	-3.34%	4.60%	-7.06%	-1.00%

Source: S&P Capital IQ. Standard template. Financial Sources.